We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $135M
1-Year Est. Return 0.15%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+0.15%
3 Year Est. Return
-0.04%
5 Year Est. Return
-7.65%
10 Year Est. Return
–
AUM
$51.3M
AUM Growth
-$64M
Cap. Flow
-$51.7M
Cap. Flow %
-100.78%
Top 10 Hldgs %
99.97%
Holding
23
New
8
Increased
–
Reduced
–
Closed
9

Top Buys

Rank Stock Value
1
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$1.18M
2
AEUA
Anadarko Petroleum Corporation
AEUA
+$199K
3
SRCLP
Stericycle, Inc
SRCLP
+$169K
4
SFLY
Shutterfly, Inc.
SFLY
+$86.9K
5
FATE icon
Fate Therapeutics
FATE
+$59.6K

Top Sells

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$22.4M
2
SWNC
Southwestern Energy Company
SWNC
+$6.86M
3
COUP
Coupa Software Incorporated
COUP
+$1.81M
4
ZSAN
Zosano Pharma Corporation
ZSAN
+$20K
5
RNGR icon
Ranger Energy Services
RNGR
+$16K

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.37%
2 Industrials 0.28%
3 Consumer Discretionary 0.2%
4 Healthcare 0.13%
5 Energy 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWO icon
1
iShares Russell 2000 Growth ETF
IWO
$14.7B
$1.17M 2.28%
+6,150
New +$1.18M
AEUA
2
DELISTED
Anadarko Petroleum Corporation
AEUA
$172K 0.34%
+5,763
New +$199K
SRCLP
3
DELISTED
Stericycle, Inc
SRCLP
$145K 0.28%
+3,209
New +$169K
SFLY
4
DELISTED
Shutterfly, Inc.
SFLY
$101K 0.2%
+1,246
New +$86.9K
FATE icon
5
Fate Therapeutics
FATE
$300M
$61K 0.12%
+6,217
New +$59.6K
TNK icon
6
Teekay Tankers
TNK
$3.2B
$12K 0.02%
+1,267
New +$12.6K
MNTA
7
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2K ﹤0.01%
+100
New +$1.67K
APVO icon
8
Aptevo Therapeutics
APVO
$3.4M
– –
0
– –
SGMO
9
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1K ﹤0.01%
+75
New +$1.6K
MDT icon
10
Medtronic
MDT
$118B
– –
-77
Closed -$6K
RNGR icon
11
Ranger Energy Services
RNGR
$396M
– –
-1,700
Closed -$16K
TNDM icon
12
Tandem Diabetes Care
TNDM
$1.38B
– –
-2,523
Closed -$6K
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
– –
-800
Closed -$7K
COUP
14
DELISTED
Coupa Software Incorporated
COUP
– –
-57,884
Closed -$1.81M
ZSAN
15
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-56
Closed -$20K
AGN
16
CALL
DELISTED
Allergan plc
AGN
– –
-58,900
Closed -$9.63M
AGN.PRA
17
DELISTED
Allergan plc
AGN.PRA
– –
-38,263
Closed -$22.4M
SWNC
18
DELISTED
Southwestern Energy Company
SWNC
– –
-576,701
Closed -$6.86M

Similar funds

WRCM
Western Reserve Capital Management Hudson, Ohio $135M AUM
SI
Stirlingshire Investments New York $135M AUM
PCMU
Paragon Capital Management (Utah) Provo, Utah $135M AUM 29.99% 1-Year Est. Return
PAG
Poinciana Advisors Group Palm Beach Gardens, Florida $135M AUM 38.46% 1-Year Est. Return
BFA
Benningfield Financial Advisors San Francisco, California $135M AUM 18.69% 1-Year Est. Return
AHIA
Andrew Hill Investment Advisors Naples, Florida $135M AUM 50.1% 1-Year Est. Return
BWS
BFI Wealth Solutions Dallas, Texas $135M AUM
OP
Oath Planning Tulsa, Oklahoma $135M AUM

Piper Sandler & Co's Q1 2018 Portfolio in Review

As of Q1 2018, Piper Sandler & Co held 23 positions worth $51.3M, down 55% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Piper Sandler & Co withdrew a net $51.7M in Q1 2018, closing 9 positions. Its most notable exit was Allergan plc, an estimated $22.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, up from 98% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Piper Sandler & Co opened a new position in iShares Russell 2000 Growth ETF worth $1.17M.

  • Piper Sandler & Co's largest Q1 2018 buy was iShares Russell 2000 Growth ETF: 6,150 shares worth $1.17M.
  • Piper Sandler & Co fully exited Allergan plc in Q1 2018, selling an estimated $22.4M.
  • Piper Sandler & Co's ten largest holdings make up 100% of its $51.3M portfolio in Q1 2018.
  • Piper Sandler & Co opened 8 new positions and closed 9 in Q1 2018.
  • Piper Sandler & Co's portfolio value fell 55% quarter-over-quarter to $51.3M.

Based on Piper Sandler & Co's 13F filing for Q1 2018, filed 15 May 2018.